Insider Trading activities at Pfizer Inc (PFE)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pfizer Inc (PFE) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pfizer Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 78003.

Total stock buying since 2005: $1,953,464.
Total stock sales since 2005: $363,276,548.
Total stock option exercises since 2005: $612,393,708.


 1   2   3 
49 insiders reported insider trading activities at Pfizer Inc (PFE):
Insider trading activities of Kindler Jeffrey B
Insider trading activities of Mckinnell Henry A
Insider trading activities of Levin Alan G
Insider trading activities of Gottlieb Scott
Insider trading activities of Katen Karen L
Insider trading activities of Mead Dana G
Insider trading activities of Lorch George A
Insider trading activities of Germano Geno J
Insider trading activities of Steere William C Jr
Insider trading activities of Olson Laurie J
Insider trading activities of Carapezzi William R Jr
Insider trading activities of Mackenzie Alexander R
Insider trading activities of Bourla Albert
Insider trading activities of Hwang Angela
Insider trading activities of Boshoff Christoffel
Insider trading activities of Cangialosi Loretta V
Insider trading activities of Cornwell W Don
Insider trading activities of Lund-jurgensen Kirsten
Insider trading activities of Burns M Anthony
Insider trading activities of Kilts James M
Insider trading activities of Ricciardi Natale S
Insider trading activities of Schulman Amy W
Insider trading activities of Mcleod Mary S
Insider trading activities of Dolsten Mikael
Insider trading activities of Lankler Douglas M
Insider trading activities of Damelio Frank A
Insider trading activities of Susman Sally
Insider trading activities of Feczko Joseph M
Insider trading activities of Gray Iii William H
Insider trading activities of Young John D
Insider trading activities of Brandicourt Olivier
Insider trading activities of Hill Charles H
Insider trading activities of Lamattina John L
Insider trading activities of Peck Kristin C
Insider trading activities of Rogers Dawn
Insider trading activities of Sahni Payal
Insider trading activities of Goettler Michael
Insider trading activities of Fonseca Lidia
Insider trading activities of Johnson Rady A
Insider trading activities of Lewis-hall Freda C
Insider trading activities of Mcdermott Michael
Insider trading activities of Burt Robert N
Insider trading activities of Read Ian C
Insider trading activities of Blaylock Ronald E
Insider trading activities of Nora Johnson Suzanne M
Insider trading activities of Maddaluna Anthony J
Insider trading activities of Shedlarz David L
Insider trading activities of Smith James C
Insider trading activities of Damico Jennifer B.

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Pfizer Inc (PFE).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 19,457 $499,072 2,500 $64,825 2,424,938 $75,547,913
2024 1,000 $28,240 5,154 $147,713 360,145 $9,846,361
2023 5,000 $156,406 9,912 $396,678 344,694 $9,372,285
2022 0 $0 144,709 $7,188,850 730,491 $20,011,756
2021 0 $0 387,163 $19,952,499 1,733,598 $40,810,764
2020 14,000 $538,407 367,010 $14,617,887 1,206,384 $37,688,196
2019 3,000 $104,160 1,128,341 $48,918,114 4,095,964 $96,886,509
2018 0 $0 1,276,366 $47,938,736 4,671,282 $115,823,336
2017 0 $0 644,287 $22,038,040 1,695,997 $35,666,813
2016 1,566 $51,427 997,443 $33,663,651 2,458,189 $51,536,405
2015 0 $0 497,351 $17,181,381 1,229,800 $23,376,238
2014 0 $0 679,712 $21,093,197 1,530,892 $22,864,980
2013 758 $22,050 1,269,126 $37,544,645 1,288,312 $31,322,547
2012 0 $0 190,175 $4,594,239 100,000 $1,747,000
2011 100 $1,905 49,991 $969,973 0 $0
2010 549 $9,947 28,060 $446,196 0 $0
2009 0 $0 190,322 $2,987,431 206,475 $0
2008 15,500 $317,850 24,505 $467,424 0 $0
2007 500 $12,000 585,897 $15,507,638 259,404 $4,760,062
2006 0 $0 2,368,664 $61,823,677 2,397,966 $35,132,543
2005 10,000 $212,000 210,871 $5,733,754 0 $0

Table 2. Monthly summary of insider trading at Pfizer Inc (PFE).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-03 0 $0 2,500 $64,825 0 $0
2025-02 19,457 $499,072 0 $0 2,424,938 $75,547,913
2024-10 1,000 $28,240 0 $0 0 $0
2024-08 0 $0 5,154 $147,713 0 $0
2024-02 0 $0 0 $0 360,145 $9,846,361
2023-12 3,000 $79,401 0 $0 0 $0
2023-05 2,000 $77,005 0 $0 0 $0
2023-03 0 $0 9,912 $396,678 0 $0
2023-02 0 $0 0 $0 344,694 $9,372,285
2022-06 0 $0 4,218 $227,603 0 $0
2022-05 0 $0 140,491 $6,961,247 0 $0
2022-03 0 $0 0 $0 102,460 $3,383,741
2022-02 0 $0 0 $0 628,031 $16,628,015
2021-12 0 $0 60,360 $3,259,477 194,242 $5,404,976
2021-11 0 $0 320,142 $16,403,605 199,548 $5,043,974
2021-08 0 $0 1,661 $80,217 0 $0
2021-07 0 $0 2,500 $107,150 0 $0
2021-05 0 $0 2,500 $102,050 0 $0
2021-02 0 $0 0 $0 1,339,808 $30,361,814
2020-11 0 $0 176,170 $7,388,569 0 $0
2020-08 13,000 $501,410 0 $0 0 $0
2020-06 0 $0 2,181 $78,799 0 $0
2020-05 0 $0 95,353 $3,602,913 0 $0
2020-04 0 $0 93,306 $3,547,606 0 $0

Table 3. Detailed insider trading at Pfizer Inc (PFE)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-03-04 Damico Jennifer B. (SVP & Controller) Sale 2,500 25.93 64,825
2025-02-27 Mcdermott Michael (Executive Vice President) Option Ex 48,419 31.31 1,515,998
2025-02-27 Sahni Payal (Executive Vice President) Option Ex 342,972 31.31 10,738,440
2025-02-27 Damico Jennifer B. (SVP & Controller) Option Ex 22,416 31.31 701,844
2025-02-27 Bourla Albert (Chairman & CEO) Option Ex 582,823 31.31 18,248,188
2025-02-27 Lankler Douglas M (Executive Vice President) Option Ex 313,828 31.31 9,825,954
2025-02-27 Fonseca Lidia (Executive Vice President) Option Ex 145,258 31.31 4,548,026
2025-02-27 Susman Sally (Executive Vice President) Option Ex 85,182 31.31 2,667,048
2025-02-22 Boshoff Christoffel (President, R&D) Option Ex 8,741 30.17 263,715
2025-02-22 Mcdermott Michael (Executive Vice President) Option Ex 11,125 30.17 335,641
2025-02-22 Damico Jennifer B. (SVP & Controller) Option Ex 8,741 30.17 263,715
2025-02-22 Bourla Albert (Chairman & CEO) Option Ex 238,399 30.17 7,192,497
2025-02-22 Susman Sally (Executive Vice President) Option Ex 63,573 30.17 1,917,997
2025-02-13 Blaylock Ronald E (Director) Buy 19,457 25.65 499,072
2024-10-30 Gottlieb Scott (Director) Buy 1,000 28.24 28,240
2024-08-13 Damico Jennifer B. (SVP & Controller) Sale 5,154 28.66 147,713
2024-02-23 Boshoff Christoffel (Executive Vice President) Option Ex 9,752 27.34 266,619
2024-02-23 Mcdermott Michael (Executive Vice President) Option Ex 12,412 27.34 339,344
2024-02-23 Sahni Payal (Executive Vice President) Option Ex 11,527 27.34 315,148
2024-02-23 Damico Jennifer B. (SVP & Controller) Option Ex 9,752 27.34 266,619
2024-02-23 Bourla Albert (Chairman & CEO) Option Ex 127,674 27.34 3,490,607
2024-02-23 Johnson Rady A (Executive Vice President) Option Ex 29,436 27.34 804,780
2024-02-23 Lankler Douglas M (Executive Vice President) Option Ex 95,755 27.34 2,617,941
2024-02-23 Susman Sally (Executive Vice President) Option Ex 63,837 27.34 1,745,303
2023-12-15 Gottlieb Scott (Director) Buy 3,000 26.47 79,401
2023-05-08 Gottlieb Scott (Director) Buy 1,000 38.58 38,580
2023-05-05 Gottlieb Scott (Director) Buy 1,000 38.42 38,425
2023-03-15 Damico Jennifer B. (SVP & Controller) Sale 9,912 40.02 396,678
2023-02-25 Mcdermott Michael (Executive Vice President) Option Ex 14,178 22.89 324,534
2023-02-25 Hwang Angela (President, Global Biopharma) Option Ex 20,273 22.89 464,048
2023-02-25 Johnson Rady A (Executive Vice President) Option Ex 33,654 22.89 770,340
2023-02-25 Susman Sally (Executive Vice President) Option Ex 72,984 22.89 1,670,603
2023-02-22 Mcdermott Michael (Executive Vice President) Option Ex 13,307 30.17 401,472
2023-02-22 Sahni Payal (Executive Vice President) Option Ex 15,209 30.17 458,855
2023-02-22 Damico Jennifer B. (SVP & Controller) Option Ex 10,456 30.17 315,457
2023-02-22 Hwang Angela (President, Global Biopharmaceu) Option Ex 57,032 30.17 1,720,655
2023-02-22 Johnson Rady A (Executive Vice President) Option Ex 31,558 30.17 952,104
2023-02-22 Susman Sally (Executive Vice President) Option Ex 76,043 30.17 2,294,217
2022-06-07 Damico Jennifer B. (SVP & Controller) Sale 4,218 53.96 227,603
2022-05-16 Damico Jennifer B. (SVP & Controller) Sale 4,000 50.50 202,000
2022-05-13 Sahni Payal (Executive Vice President) Sale 1,408 49.84 70,174
2022-05-12 Lankler Douglas M (Executive Vice President) Sale 38,273 49.41 1,891,068
2022-05-12 Carapezzi William R Jr (Executive Vice President) Sale 32,908 50.00 1,645,400
2022-05-11 Dolsten Mikael (President R&D) Sale 63,902 49.34 3,152,605
2022-03-03 Dolsten Mikael (President R&D) Option Ex 102,460 33.02 3,383,741
2022-02-26 Mcdermott Michael (Executive Vice President) Option Ex 12,340 25.60 315,904
2022-02-26 Damico Jennifer B. (SVP & Controller) Option Ex 9,713 25.60 248,652
2022-02-26 Lankler Douglas M (Executive Vice President) Option Ex 77,709 25.60 1,989,350
2022-02-26 Carapezzi William R Jr (Executive Vice President) Option Ex 21,193 25.60 542,540
2022-02-26 Susman Sally (Executive Vice President) Option Ex 63,580 25.60 1,627,648
2022-02-26 Damelio Frank A (Executive Vice President) Option Ex 127,160 25.60 3,255,296
2022-02-23 Damico Jennifer B. (SVP & Controller) Option Ex 11,748 27.34 321,190
2022-02-23 Johnson Rady A (Executive Vice President) Option Ex 35,457 27.34 969,394
2022-02-23 Lankler Douglas M (Executive Vice President) Option Ex 115,342 27.34 3,153,450
2022-02-23 Damelio Frank A (Executive Vice President) Option Ex 153,789 27.34 4,204,591
2021-12-17 Bourla Albert (Chairman & CEO) Option Ex 123,055 26.47 3,257,265
2021-12-17 Dolsten Mikael (President R&D) Option Ex 71,187 30.17 2,147,711
2021-12-03 Johnson Rady A (Executive Vice President) Sale 19,000 53.44 1,015,284
2021-12-02 Mackenzie Alexander R (Executive Vice President) Sale 41,360 54.26 2,244,193
2021-11-26 Lankler Douglas M (Executive Vice President) Sale 40,000 54.38 2,175,280
2021-11-26 Susman Sally (Executive Vice President) Sale 44,308 54.52 2,415,627
2021-11-12 Hwang Angela (Group President) Sale 26,170 49.60 1,298,162
2021-11-11 Young John D (Group President) Sale 150,000 50.09 7,512,900
2021-11-11 Dolsten Mikael (President R&D) Sale 59,664 50.31 3,001,636
2021-11-11 Dolsten Mikael (President R&D) Option Ex 199,548 25.28 5,043,974
2021-08-13 Damico Jennifer B. (SVP & Controller) Sale 1,661 48.30 80,217
2021-07-30 Damico Jennifer B. (SVP & Controller) Sale 2,500 42.86 107,150
2021-05-05 Damico Jennifer B. (SVP & Controller) Sale 2,500 40.82 102,050
2021-02-27 Damico Jennifer B. (SVP & Controller) Option Ex 9,886 22.35 220,952
2021-02-27 Hwang Angela (Group President) Option Ex 9,886 22.35 220,952
2021-02-27 Mackenzie Alexander R (Executive Vice President) Option Ex 29,838 22.35 666,879
2021-02-27 Bourla Albert (Chairman & CEO) Option Ex 53,925 22.35 1,205,223
2021-02-27 Johnson Rady A (Executive Vice President) Option Ex 25,165 22.35 562,437
2021-02-27 Young John D (Group President) Option Ex 129,419 22.35 2,892,514
2021-02-27 Lankler Douglas M (Executive Vice President) Option Ex 53,925 22.35 1,205,223
2021-02-27 Carapezzi William R Jr (Executive Vice President) Option Ex 21,570 22.35 482,089
2021-02-27 Susman Sally (Executive Vice President) Option Ex 71,899 22.35 1,606,942
2021-02-27 Damelio Frank A (Executive Vice President) Option Ex 152,785 22.35 3,414,744
2021-02-25 Sahni Payal (Executive Vice President) Option Ex 9,982 22.89 228,487
2021-02-25 Damico Jennifer B. (SVP & Controller) Option Ex 12,477 22.89 285,598
2021-02-25 Hwang Angela (Group President) Option Ex 22,686 22.89 519,282
2021-02-25 Bourla Albert (Chairman & CEO) Option Ex 163,334 22.86 3,733,815
2021-02-25 Johnson Rady A (Executive Vice President) Option Ex 37,658 22.89 861,991
2021-02-25 Young John D (Group President) Option Ex 163,334 22.89 3,738,715
2021-02-25 Lankler Douglas M (Executive Vice President) Option Ex 99,816 22.89 2,284,788
2021-02-25 Carapezzi William R Jr (Executive Vice President) Option Ex 27,222 22.89 623,111
2021-02-25 Susman Sally (Executive Vice President) Option Ex 81,667 22.89 1,869,357
2021-02-25 Damelio Frank A (Executive Vice President) Option Ex 163,334 22.89 3,738,715
2020-11-09 Bourla Albert (Chairman & CEO) Sale 132,508 41.94 5,557,385
2020-11-09 Susman Sally (Executive Vice President) Sale 43,662 41.94 1,831,184
2020-08-06 Blaylock Ronald E (Director) Buy 13,000 38.57 501,410
2020-06-05 Damico Jennifer B. (SVP & Controller) Sale 2,181 36.13 78,799
2020-05-18 Dolsten Mikael (President R&D) Sale 95,353 37.78 3,602,913
2020-04-29 Damico Jennifer B. (SVP & Controller) Sale 2,181 38.35 83,641
2020-04-29 Rogers Dawn (Executive Vice President) Sale 13,000 38.13 495,690
2020-04-29 Johnson Rady A (Executive Vice President) Sale 13,125 38.36 503,475
2020-04-29 Lankler Douglas M (Executive Vice President) Sale 65,000 37.92 2,464,800
2020-02-28 Goettler Michael (Group President) Option Ex 22,852 27.37 625,459
2020-02-28 Rogers Dawn (Executive Vice President) Option Ex 17,824 27.37 487,842
2020-02-28 Mackenzie Alexander R (Executive Vice President) Option Ex 37,934 27.37 1,038,253
2020-02-28 Bourla Albert (Chairman & CEO) Option Ex 33,135 27.37 906,904
2020-02-28 Johnson Rady A (Executive Vice President) Option Ex 15,996 27.37 437,810
2020-02-28 Young John D (Group President) Option Ex 100,548 27.37 2,751,998
2020-02-28 Lankler Douglas M (Executive Vice President) Option Ex 38,848 27.37 1,063,269
2020-02-28 Susman Sally (Executive Vice President) Option Ex 91,408 27.37 2,501,836
2020-02-28 Damelio Frank A (Executive Vice President) Option Ex 173,675 27.37 4,753,484
2020-02-28 Cangialosi Loretta V (Sr. Vice President, Controller) Option Ex 27,422 27.37 750,540
2020-02-26 Goettler Michael (Group President) Option Ex 20,129 34.59 696,262
2020-02-26 Rogers Dawn (Executive Vice President) Option Ex 15,097 34.59 522,205
2020-02-26 Hwang Angela (Group President) Option Ex 14,493 34.59 501,312
2020-02-26 Bourla Albert (Chairman & CEO) Option Ex 88,567 34.59 3,063,532
2020-02-26 Johnson Rady A (Executive Vice President) Option Ex 33,414 34.59 1,155,790
2020-02-26 Young John D (Group President) Option Ex 144,928 34.59 5,013,059
2020-02-26 Lankler Douglas M (Executive Vice President) Option Ex 88,567 34.59 3,063,532
2020-02-26 Susman Sally (Executive Vice President) Option Ex 72,464 34.59 2,506,529
2020-02-26 Damelio Frank A (Executive Vice President) Option Ex 144,928 34.59 5,013,059
2020-02-26 Cangialosi Loretta V (Sr. Vice President, Controller) Option Ex 24,155 34.59 835,521
2020-01-30 Gottlieb Scott (Director) Buy 1,000 37.00 36,997
2019-08-23 Gottlieb Scott (Director) Buy 3,000 34.72 104,160
2019-07-02 Damelio Frank A (Executive Vice President) Sale 153,184 44.09 6,754,648
2019-06-20 Mackenzie Alexander R (Executive Vice President) Sale 30,000 44.00 1,320,000
2019-04-01 Mackenzie Alexander R (Executive Vice President) Sale 15,000 42.80 642,015
2019-03-15 Johnson Rady A (Executive Vice President) Sale 8,700 41.13 357,831
2019-03-04 Rogers Dawn (Executive Vice President) Sale 15,002 42.98 644,860
2019-03-04 Dolsten Mikael (President R&D) Sale 49,082 43.54 2,137,030
2019-03-04 Read Ian C (Executive Chairman) Sale 580,866 43.29 25,155,928
2019-03-04 Susman Sally (Executive Vice President) Sale 72,723 43.23 3,141,339
2019-03-01 Dolsten Mikael (President R&D) Sale 100,471 43.58 4,378,023
2019-03-01 Dolsten Mikael (President R&D) Option Ex 106,191 31.41 3,335,459
2019-02-27 Goettler Michael (Group President) Option Ex 30,017 32.23 967,447
2019-02-27 Rogers Dawn (Executive Vice President) Option Ex 19,297 32.23 621,942
2019-02-27 Hwang Angela (Group President) Option Ex 11,792 32.23 380,056
2019-02-27 Bourla Albert (Chief Executive Officer) Option Ex 64,322 32.23 2,073,098
2019-02-27 Johnson Rady A (Executive Vice President) Option Ex 30,017 32.23 967,447
2019-02-27 Young John D (Group President) Option Ex 154,374 32.23 4,975,474
2019-02-27 Lankler Douglas M (Executive Vice President) Option Ex 64,322 32.23 2,073,098
2019-02-27 Lewis-hall Freda C (Executive Vice President) Option Ex 81,475 32.23 2,625,939
2019-02-27 Susman Sally (Executive Vice President) Option Ex 85,763 32.23 2,764,141
2019-02-27 Damelio Frank A (Executive Vice President) Option Ex 182,247 32.23 5,873,820
2019-02-27 Cangialosi Loretta V (Sr. Vice President, Controller) Option Ex 25,729 32.23 829,245
2019-02-23 Goettler Michael (Group President) Option Ex 57,870 21.03 1,217,004
2019-02-23 Rogers Dawn (Executive Vice President) Option Ex 57,870 21.03 1,217,004
2019-02-23 Mackenzie Alexander R (Executive Vice President) Option Ex 124,845 21.03 2,625,489
2019-02-23 Bourla Albert (Chief Executive Officer) Option Ex 108,024 21.03 2,271,744
2019-02-23 Johnson Rady A (Executive Vice President) Option Ex 54,012 21.03 1,135,872
2019-02-23 Young John D (Group President) Option Ex 131,172 21.03 2,758,545
2019-02-23 Lankler Douglas M (Executive Vice President) Option Ex 131,172 21.03 2,758,545
2019-02-23 Lewis-hall Freda C (Executive Vice President) Option Ex 262,347 21.03 5,517,156
2019-02-23 Susman Sally (Executive Vice President) Option Ex 293,211 21.03 6,166,227
2019-02-23 Damelio Frank A (Executive Vice President) Option Ex 555,555 21.03 11,683,320
 1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of PFE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pfizer Inc (symbol PFE, CIK number 78003) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.